Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial

Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov interface as revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-19T14:39:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The trial record now reports “Results Submitted” instead of “No Results Posted,” indicating that results have been sent to ClinicalTrials.gov but are not necessarily publicly posted yet.
    Difference
    0.1%
    Check dated 2026-10-12T14:40:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating a newer version of the page's documentation.
    Difference
    0.0%
    Check dated 2026-09-21T21:53:50.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 in the page header, indicating a small site maintenance or update to the Record History view.
    Difference
    0.0%
    Check dated 2026-08-31T18:28:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Record History now shows the latest site revision as v3.6.5, replacing the previous v3.6.4.
    Difference
    0.0%
    Check dated 2026-08-10T14:31:36.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.6.4, is added to the history, replacing Revision: v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-27T06:35:11.000Z thumbnail image

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.